Gossamer Bio, Inc.

Gossamer Bio, Inc.

SECTOR:

Oncology

FUND/VEHICLE:

NFLS Direct Investment

INVESTMENT DATE:

2018

GEOGRAPHY:

North America

STATUS CURRENT/FORMER INVESTMENT:

Former

WEBSITE:

Gossamer Bio is developing multiple candidate products that are designed to modulate the immune system in order to treat the autoimmune diseases and cancers.